Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Wuwu Biotechnology Co., Ltd. is a high-tech biopharmaceutical listed enterprise (securities code: 300357). Our company only develops innovative drugs with significant technological or market advantages (including traditional Chinese medicine or natural drugs with definite therapeutic effects, stem cell drugs) or products with similar medical functions, new medical devices, and independently develops, invests in, or acquires technologies, products, or enterprises that meet these standards. Our company has a market position including but not limited to patent protection, which is our basic product development strategy. |
| Headquarter | Huzhou |
| Establish Date | 9/19/2002 |
| Listed Code | 300357.SZ |
| Listed Date | 1/21/2014 |
| Chairman | Hu Gengxi. |
| CEO | Hu Gengxi. |
| Website | www.wolwobiotech.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
